An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover Bioequivalence Study Comparing Pantoprazole Sodium 40 mg Delayed Release Tablets (Containing 45.1 mg of Pantoprazole Sodium Sesquihydrate is Equivalent to 40 mg of Pantoprazole) of OHM Laboratories Inc. USA (a Subsidiary of Ranbaxy Pharmaceuticals Inc. USA) With PROTONIX 40 mg Delayed Release Tablets (Containing 45.1 mg of Pantoprazole Sodium Sesquihydrate is Equivalent to 40 mg of Pantoprazole) of Wyeth Laboratories in Healthy, Adult, Human, Male Subjects Under Fed Conditions.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux; Peptic ulcer
- Focus Pharmacokinetics
- 10 Aug 2012 New trial record
- 01 Aug 2012 Biomarkers information updated